IQVIA MedTech NV
ActiveFrom the official registers: KBO 20 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
The computed 12-month bankruptcy probability of IQVIA MedTech NV is 2.1% (moderate). For IQVIA MedTech NV, at least two annual filings are missing. The 2023 annual accounts show equity of €34.2m and a net result of -€3.5m. Equity has been growing by about 49% per year since 2018. Its solvency ranks better than 74% of 1,096 sector peers (NACE 71, financial year 2023). The company has been active since 2005 and the Belgian Official Gazette contains no insolvency or warning signals.
Overview
Official details
KBO- Status
- Active since 18-05-2005 Normal situation
- Legal form
- Public limited company
- Registered office
- Berchemstadionstraat 78, 2600 Antwerpen
- Activity
- Other technical testing and analysis NACE 71209and 3 others
- Establishment unit
- 2.147.958.892 2600 Antwerpen, since 12-07-2005
- Financial year end
- 31 December
- Peppol
- Reachable
Board and ownership
Board
- Emmanuel VanderhaegenDirector · since 01-02-2023
- Clément VanthournhoutDirector · since 06-07-2023
- Patrick Van DoorenDirector · since 06-07-2023
- Auditor
- Mazars Bedrijfsrevisoren CV
Shareholders
Financial position
- Bankruptcy probabilitywithin 12 months
- 2.1%
2023 figures too old to score
Annual accounts 2023
- Turnover
- €5.6m
- ▼ 64.0%
- Loss
- €3.5m
- Equity
- €34.2m
- ▲ 205%
- Total assets
- €52.2m
- ▲ 118%
- Staff
- 31.6 FTE
- =
2024 accounts not filed, 458 days past the deadline
Filed on 23-12-2024PDF
Signalsraises riskFigures for financial year 2023 (filed on 24-12-2024)2 financial years not filed after the legal deadline; last filed accounts filed 145 days late; 2 of the last 3 accounts lateLoss of €3.5m (financial year 2023)Two or more financial years not filed2023 accounts filed 145 days latelowers riskSector: Architectural and engineering activities; technical testing and analysis (NACE 71)Show the evidence
Bankruptcy probability
No current score
Figures too old
The latest figures are for FY 2023. They are too old for a current score.
Filing: At least two annual filings are missing
Financial strength, FY 2023 · tick: 2022
Average
Solvency
90+18
equity 65.5% of total assets
Liquidity
47=
short-term debt 33.7% · cash 9.6%
Profitability
10-51
return on assets -6.8%
Bankruptcy probability within 12 months
2.1%
Moderate
0%0.5%1.5%4%10%≥ 25%
About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 1.7%
12-2024: 1.7%● unchanged vs 11-2024
01-2025: 0.6%▼ -1.1 percentage points vs 12-2024
02-2025: 0.6%● unchanged vs 01-2025
03-2025: 0.6%● unchanged vs 02-2025
04-2025: 0.6%● unchanged vs 03-2025
05-2025: 0.5%▼ -0.1 percentage points vs 04-2025
06-2025: 0.5%● unchanged vs 05-2025
07-2025: 0.5%● unchanged vs 06-2025
08-2025: 0.7%▲ +0.2 percentage points vs 07-2025
09-2025: 0.4%▼ -0.3 percentage points vs 08-2025lowest value
10-2025: 0.5%▲ +0.1 percentage points vs 09-2025
11-2025: 0.6%▲ +0.1 percentage points vs 10-2025
12-2025: 0.7%▲ +0.1 percentage points vs 11-2025
01-2026: 1.5%▲ +0.8 percentage points vs 12-2025
02-2026: 1.5%● unchanged vs 01-2026
03-2026: 1.5%● unchanged vs 02-2026
04-2026: 1.3%▼ -0.2 percentage points vs 03-2026
05-2026: 1.3%● unchanged vs 04-2026
06-2026: 1.3%● unchanged vs 05-2026
07-2026: 1.3%● unchanged vs 06-2026
08-2026: 2.1%▲ +0.8 percentage points vs 07-2026highest value
09-2026: 2.1%● unchanged vs 08-2026highest value
10-2026: 2.1%● unchanged vs 09-2026
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Six signals.
lowers riskraises risk
raises risk · Two or more financial years not filed
Since the financial year that closed on 31-12-2024, 2 financial years are missing at the National Bank. A company this far behind goes bankrupt within the year nineteen times as often as a punctual filer.
NBB · 8 filingsPosition against the passed deadline
31-12-2024 year end31-07-2025 deadline01-11-2026 today
raises risk · 2023 accounts filed 145 days late
The financial year that closed on 31-12-2023 was due by 31-07-2024 and was filed on 23-12-2024, 145 days past the deadline. Measured on financial year 2023: of the companies more than 90 days late, 5.61% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers.
NBB · 8 filingsDeviation from the deadline
2025
not filed
2024
not filed
2023
145 days late
2022
592 days late
2021
3 days early
2020
26 days early
2019
1 day early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 5 accounts on average 141 days after the deadline. In the sector (NACE 71), the median for financial year 2024 was 8 days before the deadline, and 34% of those companies filed late.
Searched, nothing found (1)
Key points
Documents
Annual accounts at the NBB
- Annual accounts 2023filed on 23-12-2024
- Annual accounts 2022filed on 14-03-2025
- Annual accounts 2021filed on 28-07-2022
- Annual accounts 2020filed on 05-07-2021
Acts in the Belgian Official Gazette
- Registered office · Resignations & appointmentsact of 03-08-2023
- Resignations & appointmentsact of 01-03-2023
- Resignations & appointmentsact of 05-09-2022
- Resignations & appointmentsact of 17-08-2022
Articles and registers
- Coordinated articles of associationnotaries' database
- Entry in the KBO registerKBO Public Search
Key facts about IQVIA MedTech NV
- What is the company number of IQVIA MedTech NV?
- The company number of IQVIA MedTech NV is 0873.863.003. The VAT number is the same number with BE in front: BE 0873.863.003.
- Where is IQVIA MedTech NV based?
- The registered office is at Berchemstadionstraat 78, 2600 Antwerpen.Company details
- What does IQVIA MedTech NV do?
- According to the KBO register, the main activity is other technical testing and analysis (NACE 71209).
- What is the legal form of IQVIA MedTech NV?
- The legal form of IQVIA MedTech NV is Public limited company (NV).
- When was IQVIA MedTech NV founded?
- IQVIA MedTech NV was founded on 18-05-2005.
- Is IQVIA MedTech NV still active?
- Yes, IQVIA MedTech NV is an active enterprise in the KBO register.
- How many employees does IQVIA MedTech NV have?
- IQVIA MedTech NV had an average of 31.6 full-time equivalents in financial year 2023, according to the filed annual accounts.Financials
- What is the turnover of IQVIA MedTech NV?
- The turnover of IQVIA MedTech NV was €5.6m in financial year 2023, according to the filed annual accounts.
- Is IQVIA MedTech NV profitable?
- In financial year 2023, IQVIA MedTech NV made a loss of €3.5m.
- Where can I find the annual accounts of IQVIA MedTech NV?
- IQVIA MedTech NV filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2023.Annual accounts 2023 (PDF)
Companies linked to IQVIA MedTech NV
Comparable companies
These companies have the same main activity as IQVIA MedTech NV: other technical testing and analysis (NACE 71209). They are comparable in size and age: total assets between €14m and €53m, founded between 1989 and 2012.
| Company | Total assets | Turnover |
|---|---|---|
| IQVIA MedTech NV Antwerpen | €52.2m | €5.6m |
| IDEXX LABORATORIES Brussel | €51.1m | €19.6m |
| HRD ANTWERP Antwerpen | €14.6m | €4.3m |
| TS Holding Balen | €53.5m | €10.7m |
| CAMIN CARGO CONTROL NW EUROPE Antwerpen | €13.6m | €7.6m |
| INTERNATIONAL POST CORPORATION Brussel | €30.8m | €11.2m |
| CERTIFER BELGORAIL Brussel | €14.4m | €18.9m |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.